The tumor suppressor p53 (TP53)blocks the activity of dipeptidyl-peptidase-4 (DPP4), antagonizing erastin-inducedferroptosis in human colorectal cancer in a transcription-independent manner (Xie et al., 2017). The gene discussed is TP53; the disease is colorectal cancer.